Literature DB >> 26787547

Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1.

Jia Guo1, Stefanie Thiess1, Inger Johansson1, Souren Mkrtchian1, Magnus Ingelman-Sundberg1.   

Abstract

Cytochrome P450 2W1 (CYP2W1) is a colon tumor-specific enzyme, suggested as a potential target for cancer therapy. In contrast to other endoplasmic reticulum P450s, we found completely inverted ER membrane topology of CYP2W1 using different approaches (redox sensitive luciferase assay and protease protection assay) and demonstrated that canonical CYP reductants, cytochrome P450 reductase, and cytochrome b5 cannot serve as electron donors for CYP2W1. Moreover, the reduced catalytic activity of the Asn177 mutant that is modified by glycan moieties in the wild-type enzyme indicates a functional relevance of CYP2W1 glycosylation.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  P450 reductase; cytochrome P450 2W1; cytochrome b5; electron donor; glycosylation; membrane topology

Mesh:

Substances:

Year:  2016        PMID: 26787547     DOI: 10.1002/1873-3468.12063

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents.

Authors:  Aaron G Bart; Goreti Morais; Venu R Vangala; Paul M Loadman; Klaus Pors; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2021-10-04       Impact factor: 3.922

2.  Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer.

Authors:  Daniela Presa; Syed A Khurram; Amir Z A Zubir; Sneha Smarakan; Patricia A Cooper; Goreti R Morais; Maria Sadiq; Mark Sutherland; Paul M Loadman; James McCaul; Steven D Shnyder; Laurence H Patterson; Klaus Pors
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

3.  Micro RNA-4651 Serves as a Potential Biomarker for Prognosis When Selecting Hepatocellular Carcinoma Patients for Postoperative Adjuvant Transarterial Chemoembolization Therapy.

Authors:  Tian-Qi Zhang; Qun-Qing Su; Xiao-Ying Huang; Jin-Guang Yao; Chao Wang; Qiang Xia; Xi-Dai Long; Yun Ma
Journal:  Hepatol Commun       Date:  2018-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.